Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2026-01-08 00:00:00 ET · period of report 2026-01-06 · accession 0001628280-26-001385 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-08 | 2026-01-06 | BLFS | Foster Karen A. | Chief Quality, Ops | S - Sale | $25.59 | -335 | 192.0K | -0.2% | -$8,573 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-06 | S | D | 335 | $25.59 | 191,984 | D | — | — |